abstract |
【Task】 The present invention relates to the field of prevention and treatment of clinical conditions including cancer, autoimmune diseases, and infectious diseases. In particular, vaccine compositions comprising PD-L1 or peptide fragments thereof capable of eliciting an immune response useful for the treatment of cancer, autoimmune diseases, and infectious diseases are provided. [Selection] Figure 1 |